CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Anatomical-Outcomes-from-the-LIGHTSITE-III-Trial/35947/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Sustaining-Visual-Benefits-of-Photobiomodulation-in-Dry-Age-Related-Macular-Degeneration/35948/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Best-Practices-for-Optimized-Photobiomodulation-Treatment-Effect-Candidate-Selection/35949/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Patient-Centered-Care-and-Integration-of-Photobiomodulation-Therapy-into-Clinical-Practice/35950/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Integration-of-Photobiomodulation-Therapy-into-the-Age-Related-Macular-Degeneration-Treatment-Landscape/35951/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Real-World-Evidence-of-Photobiomodulation-Efficacy-in-Ocular-Indications/35952/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile,

A wider view – Tangata whenua and indigenous wisdom – changes to forestry practices in the region – can tourism be climate friendly? – A just transition – where to next for Rachel Sanson?

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: C. Buddy Creech, MD, MPH Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP Pediatric influenza vaccination rates are consistently lower than other childhood immunizations, a problem that’s often driven by parental hesitancy. Whether it's a lack of understanding of the possible severity of the flu or deeply held beliefs about the vaccine's safety, knowing how to address parents' concerns is key to improving uptake and

Guest: Ruth Carrico, PhD, DNP, APRN* Despite high uptake of the quadrivalent meningococcal ACWY vaccine among adolescents, significant protection gaps remain, particularly against serogroup B. That’s why Dr. Ruth Carrico joins us to examine key challenges in adolescent vaccine delivery and how newer pentavalent vaccines covering all five major meningococcal serogroups—A, C, W, Y, and B—can streamline protection, improve coverage, reduce missed doses, and support shared decision-making

Guest: Ruth Carrico, PhD, DNP, APRN* In the post-COVID landscape, healthcare providers face a new communication challenge: countering misinformation while building trust in vaccine recommendations. To help combat this, Dr. Ruth Carrico joins us to share how her approach to patient engagement has shifted from simply informing to actively listening and collaborating. Dr. Carrico is a family nurse practitioner based in Louisville, Kentucky and an Adjunct Professor in the Division of

Faculty: Shikha Wadhwani, MD Faculty: Dana Rizk, MD For the second episode of the KDIGO IgA Nephropathy (IgAN) podcast series, Dr. Dana Rizk and Dr. Shikha Wadhwani discuss the IgAN treatment revolution. The conversation explores how a deeper understanding of the disease's pathophysiology has led to new therapeutic options, moving beyond traditional supportive care. Key topics include: The shift in IgAN treatment since the KDIGO 2021 guidelines a The four-hit hypothesis of

In this episode of the Solar Maverick Podcast, host Benoy Thanjan sits down with Marty McKewon, Director of Renewable Energy and Chief Meteorologist at Indji Systems, during RE+ Las Vegas, the largest renewable energy conference in North America.Marty shares his expertise on how extreme weather events like hail, hurricanes, lightning, and other climate-driven risks how impact solar energy production and what operators can do to mitigate these threats. The conversation highlights the growing

Dr. Barry Dworkin opens the phone lines and takes your texts!

Previsioni meteo Toscana del 22-9-2025

Previsioni meteo Toscana del 22-9-2025

Eye On The Night Sky For Monday, September 22